Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control

Abstract Aims/Introduction Painful diabetic peripheral neuropathy (pDPN) is associated with small nerve fiber degeneration and regeneration. This study investigated whether the presence of pDPN might influence nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control....

Full description

Bibliographic Details
Main Authors: Georgios Ponirakis, Muhammad A Abdul‐Ghani, Amin Jayyousi, Mahmoud A Zirie, Murtaza Qazi, Hamad Almuhannadi, Ioannis N Petropoulos, Adnan Khan, Hoda Gad, Osama Migahid, Ayman Megahed, Salma Al‐Mohannadi, Fatema AlMarri, Fatima Al‐Khayat, Ziyad Mahfoud, Hanadi Al Hamad, Marwan Ramadan, Ralph DeFronzo, Rayaz A Malik
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.13544
_version_ 1819148918820175872
author Georgios Ponirakis
Muhammad A Abdul‐Ghani
Amin Jayyousi
Mahmoud A Zirie
Murtaza Qazi
Hamad Almuhannadi
Ioannis N Petropoulos
Adnan Khan
Hoda Gad
Osama Migahid
Ayman Megahed
Salma Al‐Mohannadi
Fatema AlMarri
Fatima Al‐Khayat
Ziyad Mahfoud
Hanadi Al Hamad
Marwan Ramadan
Ralph DeFronzo
Rayaz A Malik
author_facet Georgios Ponirakis
Muhammad A Abdul‐Ghani
Amin Jayyousi
Mahmoud A Zirie
Murtaza Qazi
Hamad Almuhannadi
Ioannis N Petropoulos
Adnan Khan
Hoda Gad
Osama Migahid
Ayman Megahed
Salma Al‐Mohannadi
Fatema AlMarri
Fatima Al‐Khayat
Ziyad Mahfoud
Hanadi Al Hamad
Marwan Ramadan
Ralph DeFronzo
Rayaz A Malik
author_sort Georgios Ponirakis
collection DOAJ
description Abstract Aims/Introduction Painful diabetic peripheral neuropathy (pDPN) is associated with small nerve fiber degeneration and regeneration. This study investigated whether the presence of pDPN might influence nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. Materials and Methods This exploratory substudy of an open‐label randomized controlled trial undertook the Douleur Neuropathique en 4 questionnaire and assessment of electrochemical skin conductance, vibration perception threshold and corneal nerve morphology using corneal confocal microscopy in participants with and without pDPN treated with exenatide and pioglitazone or basal–bolus insulin at baseline and 1‐year follow up, and 18 controls at baseline only. Results Participants with type 2 diabetes, with (n = 13) and without (n = 28) pDPN had comparable corneal nerve fiber measures, electrochemical skin conductance and vibration perception threshold at baseline, and pDPN was not associated with the severity of DPN. There was a significant glycated hemoglobin reduction (P < 0.0001) and weight gain (P < 0.005), irrespective of therapy. Participants with pDPN showed a significant increase in corneal nerve fiber density (P < 0.05), length (P < 0.0001) and branch density (P < 0.005), and a decrease in the Douleur Neuropathique en 4 score (P < 0.01), but no change in electrochemical skin conductance or vibration perception threshold. Participants without pDPN showed a significant increase in corneal nerve branch density (P < 0.01) and no change in any other neuropathy measures. A change in the severity of painful symptoms was not associated with corneal nerve regeneration and medication for pain. Conclusions This study showed that intensive glycemic control is associated with greater corneal nerve regeneration and an improvement in the severity of pain in patients with painful diabetic neuropathy.
first_indexed 2024-12-22T13:53:21Z
format Article
id doaj.art-c8479784d7174503828ff16492e6b5cf
institution Directory Open Access Journal
issn 2040-1116
2040-1124
language English
last_indexed 2024-12-22T13:53:21Z
publishDate 2021-09-01
publisher Wiley
record_format Article
series Journal of Diabetes Investigation
spelling doaj.art-c8479784d7174503828ff16492e6b5cf2022-12-21T18:23:37ZengWileyJournal of Diabetes Investigation2040-11162040-11242021-09-011291642165010.1111/jdi.13544Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic controlGeorgios Ponirakis0Muhammad A Abdul‐Ghani1Amin Jayyousi2Mahmoud A Zirie3Murtaza Qazi4Hamad Almuhannadi5Ioannis N Petropoulos6Adnan Khan7Hoda Gad8Osama Migahid9Ayman Megahed10Salma Al‐Mohannadi11Fatema AlMarri12Fatima Al‐Khayat13Ziyad Mahfoud14Hanadi Al Hamad15Marwan Ramadan16Ralph DeFronzo17Rayaz A Malik18Weill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarNational Diabetes Center Hamad General Hospital Hamad Medical Corporation Doha QatarNational Diabetes Center Hamad General Hospital Hamad Medical Corporation Doha QatarNational Diabetes Center Hamad General Hospital Hamad Medical Corporation Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarNational Diabetes Center Hamad General Hospital Hamad Medical Corporation Doha QatarNational Diabetes Center Hamad General Hospital Hamad Medical Corporation Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarRumailah Hospital Hamad Medical Corporation Doha QatarRumailah Hospital Hamad Medical Corporation Doha QatarDivision of Diabetes University of Texas Health Science Center San Antonio Texas USAWeill Cornell Medicine‐Qatar Qatar Foundation Education City Doha QatarAbstract Aims/Introduction Painful diabetic peripheral neuropathy (pDPN) is associated with small nerve fiber degeneration and regeneration. This study investigated whether the presence of pDPN might influence nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. Materials and Methods This exploratory substudy of an open‐label randomized controlled trial undertook the Douleur Neuropathique en 4 questionnaire and assessment of electrochemical skin conductance, vibration perception threshold and corneal nerve morphology using corneal confocal microscopy in participants with and without pDPN treated with exenatide and pioglitazone or basal–bolus insulin at baseline and 1‐year follow up, and 18 controls at baseline only. Results Participants with type 2 diabetes, with (n = 13) and without (n = 28) pDPN had comparable corneal nerve fiber measures, electrochemical skin conductance and vibration perception threshold at baseline, and pDPN was not associated with the severity of DPN. There was a significant glycated hemoglobin reduction (P < 0.0001) and weight gain (P < 0.005), irrespective of therapy. Participants with pDPN showed a significant increase in corneal nerve fiber density (P < 0.05), length (P < 0.0001) and branch density (P < 0.005), and a decrease in the Douleur Neuropathique en 4 score (P < 0.01), but no change in electrochemical skin conductance or vibration perception threshold. Participants without pDPN showed a significant increase in corneal nerve branch density (P < 0.01) and no change in any other neuropathy measures. A change in the severity of painful symptoms was not associated with corneal nerve regeneration and medication for pain. Conclusions This study showed that intensive glycemic control is associated with greater corneal nerve regeneration and an improvement in the severity of pain in patients with painful diabetic neuropathy.https://doi.org/10.1111/jdi.13544Corneal confocal microscopyExenatidePainful diabetic neuropathy
spellingShingle Georgios Ponirakis
Muhammad A Abdul‐Ghani
Amin Jayyousi
Mahmoud A Zirie
Murtaza Qazi
Hamad Almuhannadi
Ioannis N Petropoulos
Adnan Khan
Hoda Gad
Osama Migahid
Ayman Megahed
Salma Al‐Mohannadi
Fatema AlMarri
Fatima Al‐Khayat
Ziyad Mahfoud
Hanadi Al Hamad
Marwan Ramadan
Ralph DeFronzo
Rayaz A Malik
Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
Journal of Diabetes Investigation
Corneal confocal microscopy
Exenatide
Painful diabetic neuropathy
title Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
title_full Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
title_fullStr Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
title_full_unstemmed Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
title_short Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
title_sort painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
topic Corneal confocal microscopy
Exenatide
Painful diabetic neuropathy
url https://doi.org/10.1111/jdi.13544
work_keys_str_mv AT georgiosponirakis painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT muhammadaabdulghani painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT aminjayyousi painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT mahmoudazirie painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT murtazaqazi painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT hamadalmuhannadi painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT ioannisnpetropoulos painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT adnankhan painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT hodagad painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT osamamigahid painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT aymanmegahed painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT salmaalmohannadi painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT fatemaalmarri painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT fatimaalkhayat painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT ziyadmahfoud painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT hanadialhamad painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT marwanramadan painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT ralphdefronzo painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol
AT rayazamalik painfuldiabeticneuropathyisassociatedwithincreasednerveregenerationinpatientswithtype2diabetesundergoingintensiveglycemiccontrol